To examine AD pathology, we assessed Aβ pathology via immunohistochemistry for Aβ, ELISA for insoluble Aβ40 and 42 in the hippocampus, and Western blot for phosphorylated tau in the hippocampus. This evidence concerns the gene MAPT and Alzheimer disease.